Core Viewpoint - The Xi'an Municipal Government has issued the "Implementation Plan for Promoting the Capacity Enhancement of the Biopharmaceutical Industry (2025-2027)", aiming to expand the chemical and biopharmaceutical industry through strategies of imitation, innovation, and transformation [1] Group 1: Industry Development Goals - The plan emphasizes the growth of the chemical and biopharmaceutical industry chain, with a focus on strengthening the foundation of chemical generic drugs [1] - By 2027, the city aims to increase the number of generic drug products by 16 and complete 2-3 IND applications for cell-based new drugs [1] - The target for the biopharmaceutical industry chain's scale is set to reach 12 billion yuan by 2027 [1] Group 2: Research and Innovation Focus - The initiative supports the development of chemical generic drugs in areas such as anesthesia, antibiotics, and cardiovascular diseases, promoting a combination of imitation and innovation [1] - It encourages the research and development of innovative drugs, including liver-targeted drugs, peptide drugs, and exosome-based stem cell drugs [1] - The plan aims to leverage resources from universities and medical institutions to enhance clinical research collaboration with pharmaceutical companies, facilitating the rapid translation of new drugs [1]
西安：到2027年全市增加仿制药产品16个 化药生物药链群产业规模力争达到120亿元
Mei Ri Jing Ji Xin Wen·2025-12-17 06:59